Analysis of the Resistance and Sensitivity Mechanisms to Teclistamab by Focusing on Single Immune Cell Examination
Analysis of the Resistance and Sensitivity Mechanisms to Teclistamab by Focusing on Single Immune Cell Examination
The aim of this study is to discover the immune and oncogenomic features that distinguish patients who respond to teclistamab from patients who are primarily resistant. Moreover, phenotypic and genotypic characteristics that occur with secondary resistance to teclistamab will be analyzed.
Inclusion Criteria:
Exclusion Criteria:
avetloiseau.herve@iuct-oncopole.fr+33 531 156 142 ext. 33
Amiens, France 80054, France
montes.lydia@chu-amiens.fr0222455482 ext. 33
Epagny Metz- Tessy, France 74370, France
forsinipiocelle@ch-annecygenevois.fr0450636144 ext. 33
macro-m@chu-caen.fr0231272633 ext. 33
ilafon@icb-cancer.fr0380294506 ext. 33
salomon.manier@chru-lille.fr0320444292 ext. 33
philippe.rey@lyon.unicancer.fr0478782737 ext. 33
l-vincent@chu-montpellier.fr0467338362 ext. 33
bertrand.arnulf@sls.aphp.fr0142499695 ext. 33
mohamad.mohty@inserm.fr0149282620 ext. 33
laurent.frenzel@aphp.fr0144495292 ext. 33
cyrille.hulin@chu-bordeaux.fr0557623372 ext. 33
lionel.karlin@chu-lyon.fr0448864309 ext. 33
xavier.leleu@chu-poitiers.fr0549444201 ext. 33
olivier.decaux@chu-rennes.fr0299287692 ext. 33
emilie.chalayer@chu-st-etienne.fr0477917061 ext. 33
perrot.aurore@iuct-oncopole.fr0531156490 ext. 33
t.chalopin@chu-tours.fr0247473712 ext. 33
c.jacquet@chru-nancy.fr0383155249 ext. 33